Literature DB >> 8388321

Involvement of phospholipase A2 activation and arachidonic acid metabolism in the cytotoxic functions of rat NK cells.

M G Cifone1, D Botti, C Festuccia, T Napolitano, E del Grosso, G Cavallo, M A Chessa, A Santoni.   

Abstract

Arachidonic acid (AA) release via phospholipase A2 (PLA2) activation and generation of eicosanoids have been implicated as playing signaling roles in a variety of cell types. Here we show evidence that interaction of fresh NK cells with membranes from sensitive or antibody (Ab)-coated targets generates eicosanoids through both cyclooxygenase (CO) and lipoxygenase (LO) pathways. Eicosanoid generation is attributable to PLA2 activation since pretreatment with PLA2 irreversible inhibitors, such as mepacrine or para-bromophenacylbromide (pBPB), completely blocks AA metabolite generation. The involvement of PLA2 or AA metabolites in the cytotoxic functions of rat NK cells has also been investigated. Treatment of effector cells with mepacrine or pBPB resulted in complete, irreversible, dose-dependent inhibition of both NK and ADCC activities, which were completely reversed by the addition of exogenous PLA2 or its hydrolysis products, AA and lysophosphatidylcholine (lysoPC). Among the metabolites of AA released by NK cells, the 5-LO product leukotriene B4 (LTB4) seems to play an important role in cytolytic activities of NK cells. Indeed, the LO inhibitor, nordihydroguaiaretic acid (NDGA), totally abrogated both NK and ADCC activities, which were restored by the addition of exogenous LTB4. However, the failure of LTB4 to reverse mepacrine or pBPB-induced inhibition of NK and ADCC suggests that its effects could be mediated by PLA2. The results are consistent with a crucial role for the target-stimulated AA release as a fundamental step in the signal transduction pathway in NK cell. Moreover, LTB4 generation seems to be responsible for further PLA2 activation in a second step leading to the amplification of response.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388321     DOI: 10.1006/cimm.1993.1109

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  6 in total

1.  Reduced degranulation of NK cells in patients with frequently recurring herpes.

Authors:  Vladimir V Murugin; Irina N Zuikova; Nina E Murugina; Andrey E Shulzhenko; Boris V Pinegin; Mikhail V Pashenkov
Journal:  Clin Vaccine Immunol       Date:  2011-07-06

2.  Interactions of selected indole derivatives with phospholipase A₂: in silico and in vitro analysis.

Authors:  Kalarickal Vijayan Dileep; Chandran Remya; Ignatius Tintu; Madathilkovilakathu Haridas; Chittalakkottu Sadasivan
Journal:  J Mol Model       Date:  2013-01-13       Impact factor: 1.810

3.  Lipoprotein lipase expression in natural killer cells and its role in their cytotoxic activity.

Authors:  J B de Sanctis; I Blanca; D Radzioch; N E Bianco
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

Review 4.  The Role of Sphingolipids in Allergic Disorders.

Authors:  Araceli Díaz-Perales; Maria M Escribese; María Garrido-Arandia; David Obeso; Elena Izquierdo-Alvarez; Jaime Tome-Amat; Domingo Barber
Journal:  Front Allergy       Date:  2021-06-14

5.  Phospholipase A2 is involved in the mechanism of activation of neutrophils by polychlorinated biphenyls.

Authors:  P K Tithof; E Schiamberg; M Peters-Golden; P E Ganey
Journal:  Environ Health Perspect       Date:  1996-01       Impact factor: 9.031

6.  Protective Effects of Intratracheally-Administered Bee Venom Phospholipase A2 on Ovalbumin-Induced Allergic Asthma in Mice.

Authors:  Kyung-Hwa Jung; Hyunjung Baek; Dasom Shin; Gihyun Lee; Sangwon Park; Sujin Lee; Dabin Choi; Woojin Kim; Hyunsu Bae
Journal:  Toxins (Basel)       Date:  2016-09-22       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.